Last minute rampaging before 5,
swipe cleaned, nicely closed

Park some capital,
keep it,
let it take root, and grow.
Harvest when matured, that is when all Malaysian done vaccinate

Despite that,
still green,
nice

Look at other healthcare counter,
almost all in uptrend,
even the pseudo health care counter start to go green.

People now buying healthcare counters, because they know, that is trending now,
and it just the beginning, the peak will be on December.

profit taking normal,
share changing hand,
create stronger support for price.

Well,
Chart wise never lie,
support by current situation.

Carepls will follow TOP 4

Seems that doggy programmed to bark the same thing, more like a BOT
I wonder at what price it will stop barking, lets just see

park some capital,
with that daily chart,
with those steps created,
by the time official vaccine out,
well, i let the future decide, haha

shouldnt cash out in topglov, the increment is slow and steady, it is still early,
more to come, that's the real thrill, knowing its potential to grow.

need fast cash, hunt counters with rumor and glove news. Fast in, Fast out

Chart wise, uptrend
QR in top profit (Bonus and div reward)
Amazing management and vision,
Now still growing and expanding,
Slowly bull, more opportunity to topup.

Invest, ALL IN

yeap, all glove counter is in bull mode,
with only common sense,
it is easy to anticipate,
no need deep thinking,
all TP and analysis already there.
even QR prove so

Dont mind stockraider, spam everywhere, try to bring people to cook counter by promoting and spamming, trap newbie

relax,
up few % daily better than breakout 20%+,
price stable, uptrend intact.

well,
these time pandemic time, pharma counter will be second in command after glove.
park some capital before it skyrocket,

Catalyst- ON- Vaccine progress every where
Covid19 raging- more medicine needed for treatment- boost sales

Next near QR will be good!

Covid ravaging,
Glove will uptrend,

Politics issue? wont matter
vaccine overhype news? passed.

TG sure slow,
because of those block.
but when it is cleared, it will be strong support.

the bright side, it give others chance to join the boat.

Even market not good,
glove will uptrend,
as long covid ravaging.

politics issue, passed
vaccine over hype news, passed

what else will stop glove,
let us see the upcoming QR,

now rm2+ boat gone,
rm3+ boat, maybe last this week

wohoooo, rm4 is coming

mobbs68, lol, desperate for cheap ticket? we feel u

KUALA LUMPUR (Oct 7): Top Glove Corp Bhd told analysts that the company will start paying dividends on a quarterly basis starting from the financial year ending Aug 31, 2021 (FY21), and that a special dividend is possible as the group moves away from its existing semi-annual payout scheme.

UOB Kay Hian Private Ltd analyst Philip Wong, who attended a recent conference call with Top Glove, wrote in a note today that should Top Glove declare any special dividends, it will be for the third quarter of FY21 (3QFY21) at the earliest.

"Based on the company’s dividend payout policy of 50% and our projected earnings, the implied dividend yield for FY21 is 7.7%. For every 10% additional payout, the dividend yield increases by 1.6%. That said, dividend yields would moderate to 2.1% and 1.2% for FY22 and FY23 respectively,” Wong said.

Wong said today that Top Glove during the conference call also provided updates on the status of the US Customs and Border Protection's (CBP) detention order on disposable gloves manufactured by two of the company’s subsidiaries, namely Top Glove Sdn Bhd and TG Medical Sdn Bhd, since July 15, 2020.

On July 16, Top Glove said in a Bursa Malaysia filing that there was a possibility the detention order may be related to foreign labour issues.

Today, Wong said Top Glove indicated during the conference call that it remained uncertain when the CBP detention order, also known as the withhold release order (WRO), will be lifted.

Wong said: "Top Glove announced a revision of its foreign worker remediation amounting to RM136 million — almost three times higher than the management’s initial expectation of RM53 million. The deviation arises from official foreign government recruitment fees, versus agency-imposed fees, discovered only through an audit interview with its foreign workers.

"The lifting of the WRO on the two subsidiaries of Top Glove now lies with the CBP with no indicative timeline. That said, [Top Glove’s] utilisation rates remain maxed out as demand remains robust with sales to North America contributing a healthy 20% of the overall sales mix. The WRO issue has been alleviated with sales diverted through other subsidiaries unaffected by the WRO. Therefore, we believe the CBP's lifting of the WRO is a non-factor for now,” he said.

Well,
it is easy to spot manipulation,
when it surge so fast,
with insignificant volume, less order but buy in large volume,
should have spot on that they buy/sell between them to push price,
should have sell yesterday or this morning for exit, less damage.
tomorrow maybe up again in the morning, and then go below rm1 after lunch break.

Mahsing has awoken,
journey to its rightful price,
towards RM1 !

Ma Xing enters medical insurance to expand profit sources
Investment consultation
Selangor Reader A asks: MAHSING Group (MAHSING, 8583) has also recently boarded the healthcare train. Is this a good thing or a bad thing? How good is its industrial business? Can this stock still be held?

Answer: Yes, the plastics division of Ma Sing Group plans to aggressively expand into medical and healthcare products. Analysts believe that the market should begin to evaluate the plastics business that the group has almost neglected in the past. It is expected that diversified actions can bring results and this business can become a new one. Sources of earnings growth.

Industrial Research recently arranged online meetings and exchanges with Mah Sing Group Executive Director Datuk Huang Baocheng, and learned that the group management plans to enter the medical and healthcare products industry through its plastic manufacturing department.

The group expects to allocate between 100 million and 150 million ringgits to acquire a small company as the start of this new investment plan. The investment will come from internal funds. The management of the group expects that it will be available in 1 to 1.5 years. To the return of investment.

Although the management of the group has not foreseen when the new business will officially start, Industrial Research believes that if the investment is realized, it is expected to see a profit contribution in the 2021 fiscal year. In the 2019 fiscal year, the plastics business will have a pre-tax profit of 18 million ringgit. In the financial year, it was 20 million ringgits, which is about 6 to 7% of the group's pre-tax profit. However, this year's profit performance may be lower due to the impact of the coronavirus.

In terms of industrial development, since the government re-launched the "Housing Campaign" (HOC) plan on June 1, 2020, the group has taken this train and immediately launched a new industrial plan, launching M Luna and M Adora in June and July respectively. The real estate plan has achieved 100% and 90% order rates when it launched the first building. The company has begun to sell the second building. These orders are converted to the signing of sales and purchase agreements and finalized as a formal transaction. It is expected that it will take some time, but In the fourth quarter of 2020, property sales are expected to remain strong and may reach management’s forecast of achieving a sales target of RM1.6 billion.

Xingye Research believes that Ma Xing Group's efforts to diversify its business will achieve certain results. It is expected that the market will begin to evaluate the potential of the group's plastics group business, and that it is a new growth opportunity ahead.

The bank maintained its "buy" recommendation and raised its target price from 73 sen to 91 sen.

This column does not make any recommendations for stock trading. All trading profits and losses are at your own risk. Before taking investment actions, please consult your securities broker according to your own investment conditions and circumstances.